婴幼儿胃食管反流相关性咳嗽治疗的初步研究

Darryl J. Adamko, Carina M. Majaesic, Christopher Skappak, Adrian B. Jones

中国当代儿科杂志 ›› 2012, Vol. 14 ›› Issue (5) : 321-327.

PDF(1185 KB)
PDF(1185 KB)
中国当代儿科杂志 ›› 2012, Vol. 14 ›› Issue (5) : 321-327.
国外儿科研究

婴幼儿胃食管反流相关性咳嗽治疗的初步研究

  • Darryl J. Adamko, Carina M. Majaesic, Christopher Skappak, Adrian B. Jones
作者信息 +

A pilot trial on the treatment of gastroesophageal reflux-related cough in infants

  • Darryl J. Adamko, Carina M. Majaesic, Christopher Skappak, Adrian B. Jones
Author information +
文章历史 +

摘要

目的:婴幼儿哮喘的诊断主要基于咳嗽及喘息等临床症状,神经系统功能正常的婴幼儿当出现过度胃食管反流时也可以出现类似症状。目前并无随机对照研究来评价单独使用质子泵抑制剂或联合促动力药在婴幼儿中应用的疗效。目的本研究的主要目的是证实在呼吸道症状提示哮喘的婴幼儿中的确存在过度胃食管反流。其次,通过随机空白对照试验,探讨使用氨基甲酰甲基胆碱和奥美拉唑治疗过度胃食管反流可否改善呼吸道症状。方法:有慢性咳嗽或喘息病史且有病史支持、pH监测异常或胃排空扫描提示胃食管反流的婴幼儿22例,随机分为4个治疗组:安慰剂+安慰剂(PP治疗组)、奥美拉唑+氨基甲酰甲基胆碱(OB治疗组)、奥美拉唑+安慰剂(OP治疗组)、氨基甲酰甲基胆碱+安慰剂(BP治疗组)。通过临床问卷调查、检查和家庭日记以及pH监测数据评估患儿上述治疗前后及奥美拉唑+氨基甲酰甲基胆碱非盲试验后的情况。结果:19例纳入数据统计。PP治疗对胃食管反流或呼吸道症状没有作用,pH监测提示胃食管反流并无减少。然而根据pH监测及家长评估,OB治疗可减少胃食管反流,同时显著减少日间咳嗽,改善呼吸,无不良反应发生。结论:对于临床表现提示慢性胃食管反流相关性咳嗽的婴幼儿,使用奥美拉唑和氨基甲酰甲基胆碱治疗是可行的选择。

Abstract

OBJECTIVE: Diagnosing asthma in infancy is largely made on the basis of the symptoms of cough and wheezing. A similar presentation can be seen in neurologically normal infants with excessive gastroesophageal reflux (GER). There are no randomized placebo controlled studies in infants using proton pump inhibitors (PPI) alone or in addition to prokinetic agents. The primary objective was to confirm the presence of excessive GER in a population of infants that also had respiratory symptoms suggestive of asthma. Second, in a randomized placebo-controlled fashion, we determined whether treatment of GER with bethanacol and omeprazole could improve these respiratory symptoms. METHODS: Infants (n=22) with a history of chronic cough and wheeze were enrolled, if they had evidence of GER by history and an abnormal pH probe or gastric emptying scan. Infants were randomly allocated to four treatment groups: placebo/placebo (PP), omeprazole plus bethanacol (OB), omeprazole/placebo (OP), bethanacol/placebo (BP). Evaluations by clinic questionnaire and exam, home diary, and pH probe data were done before, after study-medication and after open label of OB. RESULTS: Nineteen children were studied. PP did not affect GER or respiratory symptoms, and did not decrease GER measured by pH probe. In contrast, OB decreased GER as measured by pH probe indices and parental assessment. In association, OB significantly decreased daytime coughing and improved respiratory scores. No adverse effects were reported. CONCLUSIONS: In infants with a clinical presentation suggestive of chronic GER-related cough, the use of omeprazole and bethanacol appears to be viable therapeutic option.

关键词

咳嗽 / 胃食管反流 / 哮喘 / 婴幼儿

Key words

Cough / Gastroesophageal reflux / Asthma / Infant

引用本文

导出引用
Darryl J. Adamko, Carina M. Majaesic, Christopher Skappak, Adrian B. Jones. 婴幼儿胃食管反流相关性咳嗽治疗的初步研究[J]. 中国当代儿科杂志. 2012, 14(5): 321-327
Darryl J. Adamko, Carina M. Majaesic, Christopher Skappak, Adrian B. Jones. A pilot trial on the treatment of gastroesophageal reflux-related cough in infants[J]. Chinese Journal of Contemporary Pediatrics. 2012, 14(5): 321-327
中图分类号: R725.7   

参考文献

[1]Loughlin GM. Respiratory consequences of dysfunctional swallowing and aspiration[J]. DyspHagia, 1989, 3(3):126-130.

[2]Irwin RS, Madison JM, Fraire AE. The cough reflex and its relation to gastroesophageal reflux[J]. Am J Med, 2000, 108 (Suppl 4a): 73S-78S.

[3]Orenstein SR, Shalaby TM, Kelsey SF, Frankel E. Natural history of infant reflux esophagitis: symptoms and morphometric histology during one year without pharmacotherapy[J]. Am J Gastroenterol,  2006, 101(3):628-640.

[4]RudolpH CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition[J] J Pediatr Gastroenterol Nutr, 2001, 32 (Suppl 2):S1-31.

[5]Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8):1900-1920.

[6]Gouda BB, Lydon AM, Badhe A, Shorten GD. A comparison of the effects of ranitidine and omeprazole on volume and pH of gastric contents in elective surgical patients[J]. Eur J Anaesthesiol, 2004, 21(4):260-264.

[7]Kemmotsu O, Mizushima M, Morimoto Y, Numazawa R, Kaseno S, Yamamura T, et al. Effect of preanesthetic intramuscular ranitidine on gastric acidity and volume in children[J]. J Clin Anesth, 1991, 3(6):451-455.

[8]Hyman PE, Abrams C, Dubois A. Effect of metoclopramide and bethanechol on gastric emptying in infants[J]. Pediatr Res, 1985, 19(10):1029-1032.

[9]Sheikh S, Stephen T, Howell L, Eid N. Gastroesophageal reflux in infants with wheezing[J]. Pediatr Pulmonol, 1999, 28(3):181-186.

[10]Augood C, MacLennan S, Gilbert R, Logan S. Cisapride treatment for gastro-oesophageal reflux in children[J]. Cochrane Database Syst Rev, 2003(4):CD002300.

[11]Richter JE. A critical review of current medical therapy for gastroesophageal reflux disease[J]. J Clin Gastroenterol, 1986, 8 (Suppl 1):72-80.

[12]Kato S, Ebina K, Fujii K, Chiba H, Nakagawa H. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity[J]. J Pediatr, 1996, 128(3):415-421.

[13]Estevao-Costa J, Fragoso AC, Prata MJ, Campos M, Trindade E, Dias JA, et al. Gastric emptying and antireflux surgery[J]. Pediatr Surg Int, 2011, 27(4):367-371.

[14]Sachdeva P, Malhotra N, Pathikonda M, Khayyam U, Fisher RS, Maurer AH, et al. Gastric emptying of solids and liquids for evaluation for gastroparesis[J]. Dig Dis Sci,  2011, 56(4):1138-1146.

[15]Nahata MCaH, T.F. Pediatric Drug Formulary[M]. 4th ed. Philadelphia: Lippincott Williams &Wilkins 2000.

[16]Chan-Yeung M, Manfreda J, DimichWard H, Ferguson A, Watson W, Becker A. A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants[J]. Arch Pediatr Adolesc Med, 2000, 154(7):657-663.

[17]Demeester TR, Johnson LF, JosepH GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease[J]. Ann Surg,  1976, 184(4):459-470.

[18]Richter JE, Bradley LA, Demeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender[J]. Dig Dis Sci, 1992, 37(6):849-856.

[19]Nordenstedt H, Nilsson M, Johansson S, Wallander MA, Johnsen R, Hveem K, et al. The relation between gastroesophageal reflux and respiratory symptoms in a populationbased study: the nord-trondelag health survey[J]. Chest, 2006, 129(4):1051-1056.

[20]Debley JS, Carter ER, Redding GJ. Prevalence and impact of gastroesophageal reflux in adolescents with asthma: a population-based study[J]. Pediatr Pulmonol,  2006,41(5):475-481.

[21]Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia[J]. Clin Gastroenterol Hepatol, 2006, 4(4):398-407.

[22]Saglani S, Nicholson AG, Scallan M, BalfourLynn I, Rosenthal M, Payne DN, et al. Investigation of young children with severe recurrent wheeze: any clinical benefit? [J]. Eur Respir J, 2006, 27(1):29-35.

[23]Christie DL, O'Grady LR, Mack DV. Incompetent lower esophageal sphincter and gastroesophageal reflux in recurrent acute pulmonary disease of infancy and childhood[J]. J Pediatr, 1978, 93(1):23-27.

[24]Goldstein JL, Johanson JF, Suchower LJ, Brown KA. Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial[J]. Am J Gastroenterol, 2005, 100(12):2650-2657.

[25]Khoshoo V, Dhume P. Clinical response to 2 dosing regimens of lansoprazole in infants with gastroesophageal reflux[J]. J Pediatr Gastroenterol Nutr, 2008, 46(3):352-354.

[26]Chicella MF, Batres LA, Heesters MS, Dice JE. Prokinetic drug therapy in children: a review of current options[J]. Ann Pharmacother, 2005, 39(4):706-711.

[27]Machida HM, Forbes DA, Gall DG, Scott RB. Metoclopramide in gastroesophageal reflux of infancy[J]. J Pediatr, 1988, 112(3):483-487.

[28]Carroccio A, Iacono G, Montalto G, Cavataio F, Soresi M, Notarbartolo A. Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo[J]. Scand J Gastroenterol, 1994, 29(4):300-304.

[29]Farrell RL, Roling GT, Castell DO. Stimulation of the incompetent lower esophageal sphincter. A possible advance in therapy of heartburn[J]. Am J Dig Dis, 1973, 18(8):646-650.

[30]Teper AM, Kofman CD, Szulman GA, Vidaurreta SM, Maffey AF. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma[J]. Am J Respir Crit Care Med,  2005, 171(6):587-590.

[31]Merkus PJ, de Jongste JC. Inhaled corticosteroids in wheezy infants[J]. Am J Respir Crit Care Med, 2005,172(8):1058-1059.

[32]El Serag HB, Gilger M, Kuebeler M, Rabeneck L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects[J]. Gastroenterology, 2001, 121(6):1294-1299.

[33]Loughlin GM, Lefton-Greif MA. Dysfunctional swallowing and respiratory disease in children[J]. Adv Pediatr, 1994, 41:135-162.

[34]Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux[J]. Gut 2004, 53(7):1024-1031.

[35]Conley SF, Werlin SL, Beste DJ. Proximal pH-metry for diagnosis of upper airway complications of gastroesopHageal reflux[J]. J Otolaryngol, 1995, 24(5):295-298.

[36]Little JP, Matthews BL, Glock MS, Koufman JA, Reboussin DM, Loughlin CJ, et al. Extraesophageal pediatric reflux: 24-hour double-probe pH monitoring of 222 children[J]. Ann Otol Rhinol Laryngol Suppl, 1997, 169:1-16.

[37]Rosen R, Nurko S. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms[J]. Am J Gastroenterol,  2004, 99(12):2452-2458.

[38]Lopez-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen MM, Silny J, et al. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux[J]. Pediatrics, 2006, 118(2):e299-e308.

[39]Wilson SL, Thach BT, Brouillette RT, Abu-Osba YK. Coordination of breathing and swallowing in human infants[J]. J Appl Physol, 1981,50(4):851-858.

[40]Morgan WJ, Stern DA, Sherrill DL, Guerra S, Holberg CJ, Guilbert TW, et al. Outcome of asthma and wheezing in the first 6 years of life: followup through adolescence[J]. Am J Respir Crit Care Med, 2005,172(10): 1253-1258.

[41]Eid NS, Morton RL. Rational approach to the wheezy infant[J]. Paediatr Respir Rev,  2004, 5 (Suppl A): S77-S79.

[42]Gold BD. Is gastroesophageal reflux disease really a life-long disease: do babies who regurgitate grow up to be adults with GERD complications?[J]. Am J Gastroenterol,  2006, 101(3): 641-644.

[43]Khoshoo V, Edell D, Thompson A, Rubin M. Are we overprescribing antireflux medications for infants with regurgitation? [J]. Pediatrics, 2007, 120(5): 946-949.

PDF(1185 KB)

Accesses

Citation

Detail

段落导航
相关文章

/